Oral News and Research

RSS

Dentists need to be aware of medication history even in younger patients, study suggests

A new study demonstrates that many younger adult dental patients are taking medications and highlights the importance of dental providers reviewing medication histories regardless of age.

24 Jun 2021

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

A new preprint released on the medRxiv* server explores a link between immunity to SARS-CoV-2, the earlier SARS-CoV, and childhood poliovirus vaccination. Almost 90% of the world’s people have received this vaccine, but antibodies elicited by it reduce over time and are almost absent at the end of adolescence.

24 Jun 2021

Machine learning tools can help identify tooth loss

Tooth loss is often accepted as a natural part of aging, but what if there was a way to better identify those most susceptible without the need for a dental exam?

24 Jun 2021

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

Most survivors of squamous cell head and neck cancers report that their sense of taste is dulled, changed or lost during radiation treatment, causing them to lose interest in eating and diminishing their quality of life.

23 Jun 2021

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.

23 Jun 2021

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

Research led by Xin Zheng of Huazhong University of Science and Technology in Wuhan, China, found that about 90% of patients who recovered from COVID-19 continued to have IgG antibodies targeting the N-domain and receptor-binding domain of the spike protein. However, approximately 43% of patients showed signs of neutralizing antibody activity.

23 Jun 2021

Health care leaders call for action to prevent non-ventilator-associated, hospital-acquired pneumonia

A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP).

23 Jun 2021

Study highlights the impact of structural racism and residential segregation on lung cancer outcomes

Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for 80-85 percent cases of lung cancer and when diagnosed early, has a five-year survival rate of 50-80 percent.

22 Jun 2021

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

A review published in Phytotherapy Research discussed the natural anti-SARS-CoV-2 products identified based on in silico prediction. The review’s authors also illustrate the impact of many phytochemicals either alone or in combination with traditional treatments and their potential molecular mechanisms involved in SARS-CoV-2 prevention and treatment.

22 Jun 2021

Coronaviruses identified in two species of Sri Lankan bats

Researchers sampled different species of bats roosting in the Wavul Galge cave in Sri Lanka and found two species harboring alpha- and beta-coronaviruses.

22 Jun 2021

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

21 Jun 2021

CU Cancer Center secures unique SPORE grant for head and neck cancer research

Research and treatment of head and neck cancers at the University of Colorado Cancer Center reached a new level this month with a highly competitive Specialized Programs of Research Excellence grant from the National Cancer Institute.

21 Jun 2021

FDA approves oral pellets to treat children with venous thromboembolism

Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days.

21 Jun 2021

New research identifies a link between the gut microbiome and strokes

A recent study demonstrates the impact of diets that are high in choline and trimethylamine on increasing stroke severity and functional deficits.

21 Jun 2021

Tiny capsules containing cannabinoids could help treat neurological disorders

A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer’s disease, multiple sclerosis and traumatic brain injuries in the future.

21 Jun 2021

Maternal and paternal inflammatory disease can affect pregnancy outcomes

Data presented at the 2021 EULAR congress show women with rheumatoid arthritis (RA) are at increased risks of adverse pregnancy outcomes, especially pre-term birth and babies small for gestational age.

18 Jun 2021

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

New research from scientists at the University of Pennsylvania, USA, demonstrates that cyclosporine A (CSA), a calcineurin inhibitor that modulates cytokine production, may have potential antiviral properties against coronaviruses.

18 Jun 2021

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th International Conference on Malignant Lymphoma (ICML) on June 18-22, 2021.

18 Jun 2021

More than 4 out of 10 patients who received dental implants suffer complications

More than four out of ten patients who received dental implants suffered complications within a nine-year period, these are the results of a thesis presented at the University of Gothenburg.

17 Jun 2021

Supreme Court declines to overturn ACA — again

The Supreme Court on Thursday turned back its third chance to upend the Affordable Care Act, rejecting a lawsuit filed by a group of Republican state attorneys general claiming that a change made by Congress in 2017 had rendered the entire law unconstitutional.

17 Jun 2021

Oral News and Research

Dentists need to be aware of medication history even in younger patients, study suggests

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Machine learning tools can help identify tooth loss

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

Health care leaders call for action to prevent non-ventilator-associated, hospital-acquired pneumonia

Study highlights the impact of structural racism and residential segregation on lung cancer outcomes

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

Coronaviruses identified in two species of Sri Lankan bats

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

CU Cancer Center secures unique SPORE grant for head and neck cancer research

FDA approves oral pellets to treat children with venous thromboembolism

New research identifies a link between the gut microbiome and strokes

Tiny capsules containing cannabinoids could help treat neurological disorders

Maternal and paternal inflammatory disease can affect pregnancy outcomes

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

More than 4 out of 10 patients who received dental implants suffer complications

Supreme Court declines to overturn ACA — again

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News